ArticleVaccines2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.
Abstract read
In one paragraph
Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors.
Alessandra VergoriViral Immunodeficiencies Unit, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0001-6944-0686
Giulia MatusaliLaboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0002-2948-4243
Eleonora CiminiLaboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0002-2659-0868
Licia BordiLaboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Paola BorrelliLaboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0001-9389-627X
Simone LaniniViral Immunodeficiencies Unit, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Roberta PalazziAccettazione e Teleconsulto Rete Regionale Malattie Infettive, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Jessica PaulicelliViral Immunodeficiencies Unit, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0009-0008-8361-9605
Davide MariottiLaboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0002-7698-1103
Valentina MazzottaViral Immunodeficiencies Unit, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0002-0240-7504
Stefania NotariLaboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Rita CasettiLaboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Massimo FrancalanciaLaboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0003-3133-9237
Silvia RosatiEmerging Infectious Diseases Unit, National Institute for Infectious Diseases "L.Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Alessandra D'AbramoEmerging Infectious Diseases Unit, National Institute for Infectious Diseases "L.Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0002-5160-9743
Cosmina MijaLaboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Paola MencariniRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Eugenia MilozziEpatology Unit, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Emanuela CaraffaSevere and Immune-Depression Associated Infectious Diseases Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Simona SicaImaging Diagnostics Departmenti, Radioterapia Oncologica e Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00184 Rome, Italy.
Elisabetta MetafuniImaging Diagnostics Departmenti, Radioterapia Oncologica e Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00184 Rome, Italy.ORCID 0000-0002-4780-1273
Federica SoràImaging Diagnostics Departmenti, Radioterapia Oncologica e Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00184 Rome, Italy.
Angela RagoUOSD Ematologia ASL Roma 1, San Filippo Neri Hospital, 00135 Rome, Italy.
Agostina SiniscalchiUOSD Ematologia ASL Roma 1, San Filippo Neri Hospital, 00135 Rome, Italy.
Elisabetta AbruzzeseUOC Ematologia, Sant'Eugenio Hospital, 00144 Rome, Italy.ORCID 0000-0001-5228-6491
Mariagrazia GarziaUOC Ematologia e Trapianto di Cellule Staminali, San Camillo-Forlanini Hospital, 00152 Rome, Italy.
Giovanni LuziUOC Ematologia e Trapianto di Cellule Staminali, San Camillo-Forlanini Hospital, 00152 Rome, Italy.
Roberta BattistiniUOC Ematologia e Trapianto di Cellule Staminali, San Camillo-Forlanini Hospital, 00152 Rome, Italy.
Luca ProsperiniUOC Neurologia e Neurofisiopatologia, San Camillo-Forlanini Hospital, 00152 Rome, Italy.ORCID 0000-0003-3237-6267
Antonella CingolaniInfectious Diseases Institute, Policlinico A. Gemelli, 00136 Rome, Italy.
Enrico GirardiScientific Direction, National Institute for Infectious Diseases "L. Spallanzani", IRCCS, 00184 Rome, Italy.ORCID 0000-0001-8182-5896
Fabrizio MaggiLaboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0001-7489-5271
Andrea AntinoriViral Immunodeficiencies Unit, National Institute for Infectious Diseases "L. Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0003-2121-4684
OCTOPUS Study Group
Funding
Astrazeneca NA
Abstract
PubMed holds no abstract for this paper.
Indexed as
cell mediated immunityhumoral immunitypassive pre-prophylaxisSARS coronavirus
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.